Li M M, Yang Y, Long D Y, Jiang C X, Tang R B, Sang C H, Wang W, Zhao X, Guo X Y, Li S N, Li C Y, Ning M, Jia C Q, Feng L, Wen D, Zhu H, Jiang Y X, Liu F, Liu T, Dong J Z, Ma C S
Center of Arrhythmia, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Disease, Beijing 100029, China.
Zhonghua Xin Xue Guan Bing Za Zhi. 2024 Jul 24;52(7):768-776. doi: 10.3760/cma.j.cn112148-20240410-00194.
To explore the role of mechanical hemodynamic support (MHS) in mapping and catheter ablation of patients with hemodynamically unstable ventricular tachycardia (VT), report single-center experience in a cohort of consecutive patients receiving VT ablation during MHS therapy, and provide evidence-based medical evidence for clinical practice. This was a retrospective cohort study. Patients with hemodynamically unstable VT who underwent catheter ablation with MHS at Beijing Anzhen Hospital, Capital Medical University between August 2021 and December 2023 were included. Patients were divided into rescue group and preventive group according to the purpose of treatment. Their demographic data, periprocedural details, and clinical outcomes were collected and analyzed. A total of 15 patients with hemodynamically unstable VT were included (8 patients in the rescue group and 7 patients in the preventive group). The acute procedure was successful in all patients. One patient in the rescue group had surgical left ventricular assist device (LVAD) implantation, remaining 14 patients received extracorporeal membrane oxygenation (ECMO) for circulation support. ECMO decannulation was performed in 12 patients due to clinical and hemodynamic stability, of which 6 patients were decannulation immediately after surgery and the remaining patients were decannulation at 2.0 (2.5) d after surgery. Two patients in the rescue group died during the index admission due to refractory heart failure and cerebral hemorrhage. During a median follow-up of 30 d (1 d to 12 months), one patient with LVAD had one episode of ventricular fibrillation at 6 months after discharge, and no further episodes of ventricular fibrillation and/or VT occurred after treatment with antiarrhythmic drugs. No malignant ventricular arrhythmia occurred in the remaining 12 patients who were followed up. MHS contributes to the successful completion of mapping and catheter ablation in patients with hemodynamically unstable VT, providing desirable hemodynamic status for emergency and elective conditions.
为探讨机械血流动力学支持(MHS)在血流动力学不稳定的室性心动过速(VT)患者标测和导管消融中的作用,报告单中心对一组在MHS治疗期间接受VT消融的连续患者的经验,并为临床实践提供循证医学证据。这是一项回顾性队列研究。纳入2021年8月至2023年12月期间在首都医科大学附属北京安贞医院接受MHS辅助下导管消融的血流动力学不稳定VT患者。根据治疗目的将患者分为抢救组和预防组。收集并分析他们的人口统计学数据、围手术期细节和临床结局。共纳入15例血流动力学不稳定的VT患者(抢救组8例,预防组7例)。所有患者的急性期手术均成功。抢救组1例患者植入外科左心室辅助装置(LVAD),其余14例患者接受体外膜肺氧合(ECMO)进行循环支持。12例患者因临床和血流动力学稳定而拔除ECMO,其中6例患者术后立即拔除,其余患者在术后2.0(2.5)天拔除。抢救组2例患者在本次住院期间因顽固性心力衰竭和脑出血死亡。在中位随访30天(1天至12个月)期间,1例LVAD患者在出院后6个月发生1次心室颤动,经抗心律失常药物治疗后未再发生心室颤动和/或VT。其余12例接受随访的患者未发生恶性室性心律失常。MHS有助于血流动力学不稳定的VT患者成功完成标测和导管消融,为急诊和择期情况提供理想的血流动力学状态。